Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Genentech
(https://avastin.com) 📸 Data Snapshot: May 29, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE How Avastin® (bevacizumab) works for the treatment of metastatic colorectal cancer (mCRC) (https://avastin.com)
How Avastin® (bevacizumab) works for the treatment of metastatic colorectal cancer (mCRC)
Learn about Avastin® (bevacizumab) solution for IV infusion, including benefits, risks, possible side effects, patient support, and options for financial help. See full safety for more information.
NAV_HEADER_HEADING_REPEATED_BODY How Avastin® (bevacizumab) works for the treatment of metastatic colorectal cancer (mCRC) (https://avastin.com/patient/mcrc.html)
How Avastin® (bevacizumab) works for the treatment of metastatic colorectal cancer (mCRC)
Learn about Avastin® (bevacizumab) solution for IV infusion, including benefits, risks, possible side effects, patient support, and options for financial help. See full safety for more information.
NAV_HEADER_HEADING_REPEATED_BODY How Avastin® (bevacizumab) works for metastatic colorectal cancer (mCRC) (https://avastin.com/patient/mcrc/about/how-avastin-works.html)
How Avastin® (bevacizumab) works for metastatic colorectal cancer (mCRC)
Learn how Avastin® (bevacizumab) is designed to work for the treatment of metastatic colorectal cancer (mCRC). See full safety for more information.
NAV_HEADER_HEADING_REPEATED How Avastin® (bevacizumab) works for the treatment of recurrent glioblastoma (rGBM) (https://avastin.com/patient/rgbm.html)
How Avastin® (bevacizumab) works for the treatment of recurrent glioblastoma (rGBM)
Learn how Avastin® (bevacizumab) is designed to work for the treatment of recurrent glioblastoma (rGBM). See full safety for more information.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://avastin.com) How Avastin® (bevacizumab) works for the treatment of metastatic colorectal cancer (mCRC)
[IMG: Metastatic Colorectal Cancer (mCRC) treatment option] [IMG: Out-of-Pocket Support] [H2] OUT-OF-POCKET SUPPORT up to $25,000 per calendar year The Genentech Oncology Co-pay Assistance Program can help you with the out-of-pocket costs for Avastin, if you’re eligible. Let us help you understand your financial assistance options. Get Support [IMG: How Avastin® (bevacizumab) is designed to work] [H2] FIND OUT HOW AVASTIN IS DESIGNED TO WORK Avastin is a tumor-starving therapy. Read more about how it's designed to work. Learn More [IMG: Avastin® (bevacizumab) Patient Resources] [H2] PATIENT RESOURCES Find helpful information and support. Get Answers [IMG: Learn about side effects] Get answers on the possible side effects of Avastin therapy. Learn more [IMG: Avastin® (bevacizumab) Caregiver Tips] Read about being a caregiver and find resources. Learn more *Eligibility criteria and annual limits apply. Not valid for patients using federal or state government programs to pay for their medications. Patients must be taking AVASTIN for an FDA-approved indication. See full TERMS AND CONDITIONS. Avastin® (bevacizumab) is a biologic medicine designed to target and inhibit vascular endothelial growth factor (VEGF), a key protein that stimulates new blood vessel growth in tumors. By blocking VEGF, Avastin helps starve tumors of the blood and oxygen they need to grow, slowing disease progression in people with metastatic colorectal cancer (mCRC). Avastin is given as an intravenous (IV) infusion in combination with chemotherapy, typically every 2 to 3 weeks depending on your prescribed treatment plan. Treatment continues as long as your healthcare provider determines you are benefiting. Serious side effects include: GI perforation, a hole that develops in your stomach or intestine, abnormal passage in the body, wounds that don't heal, serious bleeding, severe high blood pressure, kidney problems, infusion-related reactions, severe stroke or heart problems, and nervous system and vision problems. Common side effects are high blood pressure, too much protein in the urine, nosebleeds, bleeding, back pain, headache, taste change, dry skin, Inflammation of the skin and nose, and watery eyes. It’s important to review benefits and risks with your doctor. [H4] Important Safety Information & Indication Back to Top [H3] Indication [H5] Metastatic Colorectal Cancer (mCRC) Avastin is approved to treat metastatic colorectal cancer (mCRC) for: First- or second-line treatment in combination with intravenous fluorouracil–based chemotherapy Second-line treatment when used with fluoropyrimidine-based (combined with irinotecan or oxaliplatin) chemotherapy after cancer progresses following a first-line treatment containing bevacizumab Avastin is not approved for use after surgery was used as the primary treatment in patients with colon cancer which has not spread to other parts of the body. [H3] Possible serious side effects Everyone reacts differently to Avastin therapy. So, it's important to know what the side effects are. Although some people may have a life-threatening side effect, most do not. Your doctor will stop treatment if any serious side effects occur. Be sure to contact your health care team if there are any signs of these side effects. GI perforation. A hole that develops in your stomach or intestine. Symptoms include pain in your abdomen, nausea, vomiting, constipation, or fever Abnormal passage in the body. This type of passage—known as a fistula—is an irregular connection from one part of the body to another and can sometimes be fatal Wounds that don't heal. A cut made during surgery can be slow to heal or may not fully heal. Avastin should not be used for at least 28 days before or after surgery and until surgical wounds are fully healed Serious bleeding. This includes vomiting or coughing up blood; bleeding in the stomach, brain, or spinal cord; nosebleeds; and vaginal bleeding. If you recently coughed up blood or had serious bleeding, be sure to tell your doctor Severe high blood pressure. Blood pressure that severely spikes or shows signs of affecting the brain. Blood pressure should be monitored every 2 to 3 weeks while on Avastin and after stopping treatment Kidney problems. These may be caused by too much protein in the urine and can sometimes be fatal Infusion-related reactions. These were uncommon with the first dose (less than 3% of patients). 0.4% of patients had severe reactions. Infusion-related reactions include high blood pressure or severe high blood pressure that may lead to stroke, trouble breathing, decreased oxygen in red blood cells, serious allergic reactions, chest pain, headache, tremors, and excessive sweating. Your doctor or nurse will monitor you for signs of infusion-related reactions Severe stroke or heart problems. These may include blood clots, mini-stroke, heart attack, chest pain, and your heart may become too weak to pump blood to other parts of your body (congestive heart failure). These can sometimes be fatal Nervous system and vision problems. Signs include headache, seizure, high blood pressure, sluggishness, confusion, and blindness [H3] Side effects seen most often In clinical studies across different types of cancer, some patients experienced the following side effects: High blood pressure Too much protein in the urine Nosebleeds Bleeding Back pain Headache Taste change Dry skin Inflammation of the skin Inflammation of the nose Watery eyes [H3] Avastin is not for everyone Talk to your doctor if you are: Undergoing surgery. Avastin should not be used for 28 days before or after surgery and until surgical wounds are fully healed Pregnant or think you are pregnant. Data have shown that Avastin may harm your unborn baby. Use birth control while on Avastin. If you stop Avastin, you should keep using birth control for 6 months before trying to become pregnant Planning to become pregnant. Taking Avastin could cause a woman’s ovaries to stop working and may impair her ability to have children Breastfeeding. Breastfeeding while on Avastin may harm your baby, therefore, women should not breastfeed during and for 6 months after taking Avastin For more information about your treatment or condition, talk to your doctor. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555. Please see full Product Information for additional important safety information.
SUB-PAGE (https://avastin.com/patient/mcrc.html) How Avastin® (bevacizumab) works for the treatment of metastatic colorectal cancer (mCRC)
[IMG: Metastatic Colorectal Cancer (mCRC) treatment option] [IMG: Out-of-Pocket Support] [H2] OUT-OF-POCKET SUPPORT up to $25,000 per calendar year The Genentech Oncology Co-pay Assistance Program can help you with the out-of-pocket costs for Avastin, if you’re eligible. Let us help you understand your financial assistance options. Get Support [IMG: How Avastin® (bevacizumab) is designed to work] [H2] FIND OUT HOW AVASTIN IS DESIGNED TO WORK Avastin is a tumor-starving therapy. Read more about how it's designed to work. Learn More [IMG: Avastin® (bevacizumab) Patient Resources] [H2] PATIENT RESOURCES Find helpful information and support. Get Answers [IMG: Learn about side effects] Get answers on the possible side effects of Avastin therapy. Learn more [IMG: Avastin® (bevacizumab) Caregiver Tips] Read about being a caregiver and find resources. Learn more *Eligibility criteria and annual limits apply. Not valid for patients using federal or state government programs to pay for their medications. Patients must be taking AVASTIN for an FDA-approved indication. See full TERMS AND CONDITIONS. Avastin® (bevacizumab) is a biologic medicine designed to target and inhibit vascular endothelial growth factor (VEGF), a key protein that stimulates new blood vessel growth in tumors. By blocking VEGF, Avastin helps starve tumors of the blood and oxygen they need to grow, slowing disease progression in people with metastatic colorectal cancer (mCRC). Avastin is given as an intravenous (IV) infusion in combination with chemotherapy, typically every 2 to 3 weeks depending on your prescribed treatment plan. Treatment continues as long as your healthcare provider determines you are benefiting. Serious side effects include: GI perforation, a hole that develops in your stomach or intestine, abnormal passage in the body, wounds that don't heal, serious bleeding, severe high blood pressure, kidney problems, infusion-related reactions, severe stroke or heart problems, and nervous system and vision problems. Common side effects are high blood pressure, too much protein in the urine, nosebleeds, bleeding, back pain, headache, taste change, dry skin, Inflammation of the skin and nose, and watery eyes. It’s important to review benefits and risks with your doctor. [H4] Important Safety Information & Indication Back to Top [H3] Indication [H5] Metastatic Colorectal Cancer (mCRC) Avastin is approved to treat metastatic colorectal cancer (mCRC) for: First- or second-line treatment in combination with intravenous fluorouracil–based chemotherapy Second-line treatment when used with fluoropyrimidine-based (combined with irinotecan or oxaliplatin) chemotherapy after cancer progresses following a first-line treatment containing bevacizumab Avastin is not approved for use after surgery was used as the primary treatment in patients with colon cancer which has not spread to other parts of the body. [H3] Possible serious side effects Everyone reacts differently to Avastin therapy. So, it's important to know what the side effects are. Although some people may have a life-threatening side effect, most do not. Your doctor will stop treatment if any serious side effects occur. Be sure to contact your health care team if there are any signs of these side effects. GI perforation. A hole that develops in your stomach or intestine. Symptoms include pain in your abdomen, nausea, vomiting, constipation, or fever Abnormal passage in the body. This type of passage—known as a fistula—is an irregular connection from one part of the body to another and can sometimes be fatal Wounds that don't heal. A cut made during surgery can be slow to heal or may not fully heal. Avastin should not be used for at least 28 days before or after surgery and until surgical wounds are fully healed Serious bleeding. This includes vomiting or coughing up blood; bleeding in the stomach, brain, or spinal cord; nosebleeds; and vaginal bleeding. If you recently coughed up blood or had serious bleeding, be sure to tell your doctor Severe high blood pressure. Blood pressure that severely spikes or shows signs of affecting the brain. Blood pressure should be monitored every 2 to 3 weeks while on Avastin and after stopping treatment Kidney problems. These may be caused by too much protein in the urine and can sometimes be fatal Infusion-related reactions. These were uncommon with the first dose (less than 3% of patients). 0.4% of patients had severe reactions. Infusion-related reactions include high blood pressure or severe high blood pressure that may lead to stroke, trouble breathing, decreased oxygen in red blood cells, serious allergic reactions, chest pain, headache, tremors, and excessive sweating. Your doctor or nurse will monitor you for signs of infusion-related reactions Severe stroke or heart problems. These may include blood clots, mini-stroke, heart attack, chest pain, and your heart may become too weak to pump blood to other parts of your body (congestive heart failure). These can sometimes be fatal Nervous system and vision problems. Signs include headache, seizure, high blood pressure, sluggishness, confusion, and blindness [H3] Side effects seen most often In clinical studies across different types of cancer, some patients experienced the following side effects: High blood pressure Too much protein in the urine Nosebleeds Bleeding Back pain Headache Taste change Dry skin Inflammation of the skin Inflammation of the nose Watery eyes [H3] Avastin is not for everyone Talk to your doctor if you are: Undergoing surgery. Avastin should not be used for 28 days before or after surgery and until surgical wounds are fully healed Pregnant or think you are pregnant. Data have shown that Avastin may harm your unborn baby. Use birth control while on Avastin. If you stop Avastin, you should keep using birth control for 6 months before trying to become pregnant Planning to become pregnant. Taking Avastin could cause a woman’s ovaries to stop working and may impair her ability to have children Breastfeeding. Breastfeeding while on Avastin may harm your baby, therefore, women should not breastfeed during and for 6 months after taking Avastin For more information about your treatment or condition, talk to your doctor. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555. Please see full Product Information for additional important safety information.
SUB-PAGE (https://avastin.com/patient/mcrc/about/how-avastin-works.html) How Avastin® (bevacizumab) works for metastatic colorectal cancer (mCRC)
[H1] How is Avastin designed to work? Avastin® (bevacizumab) is a tumor-starving (anti-angiogenic) therapy. Avastin is designed to block a protein called vascular endothelial growth factor, or VEGF. Normal cells make VEGF, but some cancer cells make too much VEGF. Blocking VEGF may prevent the growth of new blood vessels, including normal blood vessels and blood vessels that feed tumors. Unlike chemotherapy that attacks the cancer cells, the purpose of Avastin is to block the blood supply that feeds the tumor. This can stop the tumor from growing. [H4] Tumor before treatment New blood vessels feed the tumor so it can grow and spread. [IMG: Tumor before treatment] [H4] Tumor with Avastin and chemotherapy Avastin helps prevent blood vessels from reaching the tumor; this could starve the tumor. However, in a study of mCRC patients who continued on Avastin for second-line treatment after a first-line treatment containing bevacizumab, tumors did not shrink. [IMG: Tumor after treatment] [IMG: Financial resources calculator] [H2] GET FINANCIAL SUPPORT Questions about Avastin treatment costs? Let us help you understand your financial assistance options. Get Support [IMG: How Avastin® (bevacizumab) is designed to work] [H2] FIND OUT HOW AVASTIN IS DESIGNED TO WORK Avastin is a tumor-starving therapy. Read more about how it's designed to work. Learn More [IMG: Avastin® (bevacizumab) patient resources] [H2] PATIENT RESOURCES Find helpful information and support. Get Answers [H4] Important Safety Information & Indication Back to Top [H3] Indication [H5] Metastatic Colorectal Cancer (mCRC) Avastin is approved to treat metastatic colorectal cancer (mCRC) for: First- or second-line treatment in combination with intravenous fluorouracil–based chemotherapy Second-line treatment when used with fluoropyrimidine-based (combined with irinotecan or oxaliplatin) chemotherapy after cancer progresses following a first-line treatment containing bevacizumab Avastin is not approved for use after surgery was used as the primary treatment in patients with colon cancer which has not spread to other parts of the body. [H3] Possible serious side effects Everyone reacts differently to Avastin therapy. So, it's important to know what the side effects are. Although some people may have a life-threatening side effect, most do not. Your doctor will stop treatment if any serious side effects occur. Be sure to contact your health care team if there are any signs of these side effects. GI perforation. A hole that develops in your stomach or intestine. Symptoms include pain in your abdomen, nausea, vomiting, constipation, or fever Abnormal passage in the body. This type of passage—known as a fistula—is an irregular connection from one part of the body to another and can sometimes be fatal Wounds that don't heal. A cut made during surgery can be slow to heal or may not fully heal. Avastin should not be used for at least 28 days before or after surgery and until surgical wounds are fully healed Serious bleeding. This includes vomiting or coughing up blood; bleeding in the stomach, brain, or spinal cord; nosebleeds; and vaginal bleeding. If you recently coughed up blood or had serious bleeding, be sure to tell your doctor Severe high blood pressure. Blood pressure that severely spikes or shows signs of affecting the brain. Blood pressure should be monitored every 2 to 3 weeks while on Avastin and after stopping treatment Kidney problems. These may be caused by too much protein in the urine and can sometimes be fatal Infusion-related reactions. These were uncommon with the first dose (less than 3% of patients). 0.4% of patients had severe reactions. Infusion-related reactions include high blood pressure or severe high blood pressure that may lead to stroke, trouble breathing, decreased oxygen in red blood cells, serious allergic reactions, chest pain, headache, tremors, and excessive sweating. Your doctor or nurse will monitor you for signs of infusion-related reactions Severe stroke or heart problems. These may include blood clots, mini-stroke, heart attack, chest pain, and your heart may become too weak to pump blood to other parts of your body (congestive heart failure). These can sometimes be fatal Nervous system and vision problems. Signs include headache, seizure, high blood pressure, sluggishness, confusion, and blindness [H3] Side effects seen most often In clinical studies across different types of cancer, some patients experienced the following side effects: High blood pressure Too much protein in the urine Nosebleeds Bleeding Back pain Headache Taste change Dry skin Inflammation of the skin Inflammation of the nose Watery eyes [H3] Avastin is not for everyone Talk to your doctor if you are: Undergoing surgery. Avastin should not be used for 28 days before or after surgery and until surgical wounds are fully healed Pregnant or think you are pregnant. Data have shown that Avastin may harm your unborn baby. Use birth control while on Avastin. If you stop Avastin, you should keep using birth control for 6 months before trying to become pregnant Planning to become pregnant. Taking Avastin could cause a woman’s ovaries to stop working and may impair her ability to have children Breastfeeding. Breastfeeding while on Avastin may harm your baby, therefore, women should not breastfeed during and for 6 months after taking Avastin For more information about your treatment or condition, talk to your doctor. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555. Please see full Product Information for additional important safety information.
SUB-PAGE (https://avastin.com/patient/rgbm.html) How Avastin® (bevacizumab) works for the treatment of recurrent glioblastoma (rGBM)
[IMG: Recurrent Glioblastoma (rGBM) Treatment Option] [IMG: Out-of-Pocket Support] [H2] OUT-OF-POCKET SUPPORT up to $25,000 per calendar year The Genentech Oncology Co-pay Assistance Program can help you with the out-of-pocket costs for Avastin, if you’re eligible. Let us help you understand your financial assistance options. Get Support [IMG: How Avastin® (bevacizumab) is designed to work] [H2] FIND OUT HOW AVASTIN IS DESIGNED TO WORK Avastin is a tumor-starving therapy. Read more about how it's designed to work. Learn More [IMG: Avastin® (bevacizumab) Patient Resources] [H2] PATIENT RESOURCES Find helpful information and support. Get Answers [IMG: Learn about side effects] Get answers on the possible side effects of Avastin therapy. Learn more [IMG: Avastin® (bevacizumab) Caregiver Tips] Read about being a caregiver and find resources. Learn more *Eligibility criteria and annual limits apply. Not valid for patients using federal or state government programs to pay for their medications. Patients must be taking AVASTIN for an FDA-approved indication. See full TERMS AND CONDITIONS. Avastin® (bevacizumab) is a biologic medicine used to treat recurrent glioblastoma (rGBM) in adults whose brain tumor has progressed after prior treatment. It is designed to target and inhibit vascular endothelial growth factor (VEGF), a protein that helps tumors grow new blood vessels. By blocking VEGF, Avastin helps limit the blood and oxygen supply that rGBM tumors need to grow. Learn more about how Avastin is designed to work in recurrent glioblastoma. Avastin is given as an intravenous (IV) infusion, usually every 2 weeks for rGBM, through a vein or a port placed under the skin. Your care team will determine your treatment schedule and may continue Avastin as long as your tumor is controlled and side effects remain manageable. Like all medicines for cancer, Avastin can cause side effects. These may include high blood pressure, too much protein in the urine, nosebleeds, bleeding, back pain, headache, taste change, dry skin, inflammation of the skin, inflammation of the nose, or watery eyes. Serious side effects may include GI perforation, wounds that don’t heal, or serious bleeding. Talk with your healthcare team right away if you notice any new or worsening symptoms. [H4] Important Safety Information & Indication Back to Top [H3] Indication [H5] Glioblastoma (GBM) Avastin is approved to treat glioblastoma (GBM) in adult patients whose cancer has progressed after prior treatment (recurrent or rGBM). [H3] Possible serious side effects Everyone reacts differently to Avastin therapy. So, it's important to know what the side effects are. Although some people may have a life-threatening side effect, most do not. Your doctor will stop treatment if any serious side effects occur. Be sure to contact your health care team if there are any signs of these side effects. GI perforation. A hole that develops in your stomach or intestine. Symptoms include pain in your abdomen, nausea, vomiting, constipation, or fever Abnormal passage in the body. This type of passage—known as a fistula—is an irregular connection from one part of the body to another and can sometimes be fatal Wounds that don't heal. A cut made during surgery can be slow to heal or may not fully heal. Avastin should not be used for at least 28 days before or after surgery and until surgical wounds are fully healed Serious bleeding. This includes vomiting or coughing up blood; bleeding in the stomach, brain, or spinal cord; nosebleeds; and vaginal bleeding. If you recently coughed up blood or had serious bleeding, be sure to tell your doctor Severe high blood pressure. Blood pressure that severely spikes or shows signs of affecting the brain. Blood pressure should be monitored every 2 to 3 weeks while on Avastin and after stopping treatment Kidney problems. These may be caused by too much protein in the urine and can sometimes be fatal Infusion-related reactions. These were uncommon with the first dose (less than 3% of patients). 0.4% of patients had severe reactions. Infusion-related reactions include high blood pressure or severe high blood pressure that may lead to stroke, trouble breathing, decreased oxygen in red blood cells, serious allergic reactions, chest pain, headache, tremors, and excessive sweating. Your doctor or nurse will monitor you for signs of infusion-related reactions Severe stroke or heart problems. These may include blood clots, mini-stroke, heart attack, chest pain, and your heart may become too weak to pump blood to other parts of your body (congestive heart failure). These can sometimes be fatal Nervous system and vision problems. Signs include headache, seizure, high blood pressure, sluggishness, confusion, and blindness [H3] Side effects seen most often In clinical studies across different types of cancer, some patients experienced the following side effects: High blood pressure Too much protein in the urine Nosebleeds Bleeding Back pain Headache Taste change Dry skin Inflammation of the skin Inflammation of the nose Watery eyes [H3] Avastin is not for everyone Talk to your doctor if you are: Undergoing surgery. Avastin should not be used for 28 days before or after surgery and until surgical wounds are fully healed Pregnant or think you are pregnant. Data have shown that Avastin may harm your unborn baby. Use birth control while on Avastin. If you stop Avastin, you should keep using birth control for 6 months before trying to become pregnant Planning to become pregnant. Taking Avastin could cause a woman’s ovaries to stop working and may impair her ability to have children Breastfeeding. Breastfeeding while on Avastin may harm your baby, therefore, women should not breastfeed during and for 6 months after taking Avastin For more information about your treatment or condition, talk to your doctor. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555. Please see full Product Information for additional important safety information.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 0 |
| /patient/mcrc.html | 1 | 0 |
| /patient/mcrc/about/how-avastin-works.html | 0 | 0 |
| /patient/rgbm.html | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
/patient/mcrc.html
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
/patient/mcrc/about/how-avastin-works.html
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
/patient/rgbm.html
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Genentech has 19.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Genentech (avastin.com)
A rare example of high-integrity communication forced by regulation but executed with precision. While the site is highly repetitive, it replaces traditional marketing BS with dense clinical data and surprisingly transparent limitations of the therapy. It is a ‘Substance-First’ site where the legal disclosures provide more forensic evidence than the promotional headings.
To further reduce the BS score, Genentech should reduce the verbatim duplication of content between the homepage and the mCRC sub-page to minimize concept repetition penalties. Adding direct outbound links to ClinicalTrials.gov identifiers for the referenced studies within the body text would improve the proof path score. The trust_theatre_flag could be neutralized by integrating a more robust, verified professional review system for HCPs. Finally, adding ‘Person’ schema for the lead medical directors or clinical leads would close the minor authority gap for individual expertise.
The website perfectly aligns with the Pharma and Biotech industry classification. Its content is strictly focused on therapeutic indications, mechanism of action (VEGF inhibition), and regulatory-mandated safety disclosures for the drug Avastin.
“The score of 21 is driven primarily by industry clichés and repetition. The Information Density and Semantic Coherence pillars are extremely strong, showing almost no fluff or drift. The score remains above 10 only because of the heavy use of template language and the high number of content repetitions across the four analyzed pages.”
This training module utilizes a snapshot of public data from Genentech, captured on May 29, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Genentech: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://avastin.com to view the most current version of its content and learn from the source what this company is about and what it offers.